As the first speaker in the session, Dr. Puhr presented in his talk “The AR-Glucocorticoid Receptor Axis, an underestimated factor for PCa treatment and source for therapy failure”, including his latest findings about the AR-glucocorticoid receptor (GR) axis and its role in AR targeted therapy resistance. This evidence concerns the gene AR and posterior cortical atrophy.